跳至主要内容
临床试验/NL-OMON42321
NL-OMON42321已完成不适用

Reference values of HEPcidin Plus other Iron paramEters in children - HEPPIE study

Maxima Medisch Centrum0 个研究点目标入组 173 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
173

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 17(—)

入选标准

  • * Age 6 months to 18 years
  • * Western-European descent ((Non- Western European people may be a carrier of alpha or beta thalassemia, which may influence the results of serum hepcidin and other iron parameters)
  • * Infusion or venipuncture required for surgery or diagnostic
  • * Informed consent obtained from parents and from both parents and child in case the patient is (over)

排除标准

  • * Exprematurity (gestation <37 weeks), exdismaturity (birth weight * (status after) systemic underlying disease (malignancy, asthma, diabetes, congenital heart disease, kidney failure, congenital immunodeficiencies, etc.
  • * Known anemia
  • * Treatment with iron preparations
  • * Acute infection
  • * Trauma <48 hours ago
  • * Operation <48 hours ago
  • * Use of any medication
  • * If the laboratory results demonstrate increased inflammation parameters, the patient will be excluded afterwards

研究者

发起方
Maxima Medisch Centrum

相似试验